share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股sec公告 ·  05/06 09:19
Moomoo AI 已提取核心訊息
On May 6, 2024, Safety Shot, Inc., a Delaware-incorporated wellness and dietary supplement company, filed a Form 8-K with the SEC and issued a press release providing a comprehensive shareholder update. The update highlighted significant milestones and progress in the company's strategy to enhance long-term shareholder value. Key achievements include the successful launch of the company's flagship product, Safety Shot, a patented beverage designed to reduce blood alcohol content, which sold out on its first day on the company's website and on Amazon. Safety Shot also announced a strategic distribution agreement to expand its presence in Southern California and is preparing to launch in Las Vegas and Los Angeles retail stores by the end of Q2 2024. The company...Show More
On May 6, 2024, Safety Shot, Inc., a Delaware-incorporated wellness and dietary supplement company, filed a Form 8-K with the SEC and issued a press release providing a comprehensive shareholder update. The update highlighted significant milestones and progress in the company's strategy to enhance long-term shareholder value. Key achievements include the successful launch of the company's flagship product, Safety Shot, a patented beverage designed to reduce blood alcohol content, which sold out on its first day on the company's website and on Amazon. Safety Shot also announced a strategic distribution agreement to expand its presence in Southern California and is preparing to launch in Las Vegas and Los Angeles retail stores by the end of Q2 2024. The company is nearing the completion of a clinical trial to measure the effectiveness of Safety Shot. Additionally, Safety Shot has garnered support from a portfolio of celebrities and influencers. Management changes were also announced, including the appointment of Jarrett Boon as CEO, Jordan Schur as President and a member of the Board of Directors, John Gulyas as Chairman, David Sandler as COO, and David J. Long joining the Board. The company plans to expand its sales to distributors, retailers, restaurants, and bars in 2024. The press release also contained forward-looking statements about the company's expectations for future studies and results.
2024年5月6日,特拉華州註冊成立的健康和膳食補充劑公司Safety Shot, Inc. 向美國證券交易委員會提交了8-K表格,併發布了一份新聞稿,提供了全面的股東最新情況。最新消息強調了公司提高長期股東價值的戰略中的重要里程碑和進展。主要成就包括該公司的旗艦產品Safety Shot的成功推出,這是一種旨在降低血液中酒精含量的專利飲料,在公司網站和亞馬遜的第一天就銷售一空。Safety Shot還宣佈了一項戰略分銷協議,以擴大其在南加州的業務,並準備在2024年第二季度末之前在拉斯維加斯和洛杉磯開設零售門店。該公司即將完成一項衡量Safety Shot有效性的臨床試驗。此外,Safety...展開全部
2024年5月6日,特拉華州註冊成立的健康和膳食補充劑公司Safety Shot, Inc. 向美國證券交易委員會提交了8-K表格,併發布了一份新聞稿,提供了全面的股東最新情況。最新消息強調了公司提高長期股東價值的戰略中的重要里程碑和進展。主要成就包括該公司的旗艦產品Safety Shot的成功推出,這是一種旨在降低血液中酒精含量的專利飲料,在公司網站和亞馬遜的第一天就銷售一空。Safety Shot還宣佈了一項戰略分銷協議,以擴大其在南加州的業務,並準備在2024年第二季度末之前在拉斯維加斯和洛杉磯開設零售門店。該公司即將完成一項衡量Safety Shot有效性的臨床試驗。此外,Safety Shot還獲得了衆多名人和有影響力人士的支持。還宣佈了管理層變動,包括任命傑瑞特·布恩爲首席執行官,喬丹·舒爾爲總裁兼董事會成員,約翰·古里亞斯爲主席,戴維·桑德勒爲首席運營官,大衛·朗加入董事會。該公司計劃在2024年將其銷售範圍擴大到分銷商、零售商、餐廳和酒吧。新聞稿還包含有關公司對未來研究和結果的預期的前瞻性陳述。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息